Further mechanistic study reveals that stable MAGEA2-expressing cancer cells highly express GFRAL, while exposure of these cells with CM from Gem treated PSC activate the GFRAL-RET mediated Akt and ERK1/2 dependent cell survival pathway to further enhance their Gem resistance. The gene discussed is RET; the disease is cancer.